Holder snapshot 7 signals
Share change
-5,809,006
Put/Call ratio
119%
SEC-reported price per share
$4.26
Number of holders
80
Value change
-$26,231,441
Number of buys
35
Open additional details 1 more signal available
Number of sells
33
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,571,428,571

Security key

00653A107

Report period

Q2 2021

Institutions

80

Top holders

10

Ownership snapshot

Top reported holders of ADAPY - Adaptimmune Therapeutics PLC - American Depositary Shares, each representing 6 Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Matrix Capital Management...
Disclosed value leader
Matrix Capital Management...
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F Lead comparable stake: 2.5% Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP leads the comparable SEC ownership view at 2.5%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Comparable ownership Top 5
Matrix Capital Management Company... 2.5%
NEA Management Company, LLC 1.1%
BAILLIE GIFFORD & CO 0.73%
BAKER BROS. ADVISORS LP 0.63%
Capital World Investors 0.51%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Matrix Capital Management Company, LP
13F
Company
13F
2.5%
$206,953,000
38,974,185 shares
31 Mar 2021
NEA Management Company, LLC
13F
Company
13F
1.1%
$90,709,000
17,082,611 shares
31 Mar 2021
BAILLIE GIFFORD & CO
13F
Company
13F
0.73%
$60,892,000
11,467,517 shares
31 Mar 2021
BAKER BROS. ADVISORS LP
13F
Company
13F
0.63%
$52,202,000
9,830,877 shares
31 Mar 2021
Capital World Investors
13F
Company
13F
0.51%
$42,494,000
8,002,700 shares
31 Mar 2021
MORGAN STANLEY
13F
Company
13F
0.3%
$25,083,000
4,723,562 shares
31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
80
Shares
111,675,475
Rows available
80
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
80
Q2 2021 holders
80
Holder diff
0
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .